COMP <GO>
ILMN vs MRK // RSI-14 & 200D SMA MOMENTUM
Illumina Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ILMN 3
— MRK 12
▲ RSI-14 & 200D SMA MOMENTUM LEADER: MRK
LAST: $235.99 (-18.64%) • MKT CAP: $43.80B
rsi-technicals
38.6
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
rsi-technicals
56.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ILMN VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ILMN | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.10% | 74.80% | -8.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.20% | 20.70% | -2.50 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 47.5x | 15.3x | +32.20 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 3.42% | -1.29 | MRK | /fcf-yield <GO> |
| Operating Margin | 18.60% | 34.30% | -15.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | 19.60% | 28.10% | -8.50 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -0.70% | 1.30% | -2.00 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.52 | 5.19 | +4.33 | ILMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ILMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.60% | +0.80 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 38.6 | 56.9 | -18.28 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.92 | +0.24 | ILMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 47.9x | 18.4x | +29.50 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $43.80B | $361.02B | -$317.22B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ILMN REV | MRK REV | ILMN GROSS % | MRK GROSS % | ILMN FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.34B | $65.01B | 66.1% | 74.8% | $931.0M | $12.36B |
| FY 2024 | $4.37B | $64.17B | 65.4% | 76.3% | $709.0M | $18.10B |
| FY 2023 | $4.50B | $60.12B | 44.0% | 44.0% | $275.3M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ILMN // BETA 1.16
MRK // BETA 0.92